サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1472313

ロングリードシーケンス市場：用途別、手法別、製品別、エンドユーザー別：世界市場機会分析と産業予測、2023～2032年

Long Read Sequencing Market By Application, By Technique (Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Synthetic Long Read Sequencing), By Product, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

出版日
ページ情報
英文 395 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ロングリードシーケンス市場：用途別、手法別、製品別、エンドユーザー別：世界市場機会分析と産業予測、2023～2032年
出版日: 2024年03月01日
発行: Allied Market Research
ページ情報: 英文 395 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ロングリードシーケンス市場は、2022年に7億2,443万米ドルと評価され、2023～2032年にかけて21.7%のCAGRを示し、2032年には51億6,341万米ドルに達すると推定されます。

ロングリードシーケンスは、従来の手法と比較してより長いDNAストレッチを読み取るゲノム技術です。1分子シーケンスのような革新的な技術を採用し、数千から数100万塩基対に及ぶDNA配列を生成します。Pacific Biosciences社やOxford Nanopore Technologies社などのプラットフォームは、ナノポアシーケンスなどの技術を利用してリード長を延長しています。ロングリードシーケンスにより、複雑なゲノム領域、反復配列、構造変異の包括的な解析が容易になります。その用途には、de novoゲノムアセンブリ、複雑なゲノム構造の解明、遺伝性疾患の理解、微生物の多様性の探求などがあります。全体として、ロングリードシーケンスは、詳細かつ正確なゲノム情報を提供することで、ゲノム研究に革命をもたらします。

Long Read Sequencing Market-IMG1

遺伝性疾患とがんの有病率の上昇は、ロングリードシーケンシング術に対する需要増加の大きな原動力となっています。遺伝性疾患とがんは、突然変異、構造変異、ゲノム再配列など、複数の遺伝的要因の影響を受ける本質的に複雑な疾患です。ロングリードシーケンスは、ゲノム全体を包括的に解析する能力を提供し、研究者や臨床医がこれらの疾患に関連する希少かつ新規の遺伝子変異をより正確に同定することを可能にします。例えば、世界保健機関（WHO）は、世界中で毎年約40万人の幼児ががんに罹患していると推定しており、がんの遺伝的基盤をより良く理解し、標的療法を開発するための高度なゲノム技術が緊急に必要であることを強調しています。疾患の根底にある遺伝的メカニズムに関する洞察を提供することで、ロングリードシーケンスは、プレシジョン・メディシンのイニシアチブを推進し、遺伝性疾患やがん患者の臨床転帰を改善する上で重要な役割を果たします。

さらに、シーケンスのコストが低下し、さまざまな領域でゲノミクスの重要性に対する認識が高まる中、包括的なゲノム洞察に対する需要が高まっています。ロングリードシーケンスによってゲノムの構造と機能がより深く理解されるため、研究者は複雑な遺伝的変異を明らかにし、疾患、形質、進化のプロセスの遺伝的基盤をより深く理解することができます。このように、遺伝性疾患やがん疾患の増加、疾患診断におけるロングリードシーケンスの幅広い応用は、潜在的に市場の成長を阻害しています。

しかし、ロングリードシーケンスのセグメントでは熟練した専門家の不足が市場成長の妨げになると予想されます。ロングリードシーケンスプラットフォームからのデータの操作と解釈には、分子生物学、バイオインフォマティクス、ゲノミクスの専門知識が必要です。十分な訓練を受けた人材が不足しているため、ロングリードシーケンシング術の採用と利用が制限され、研究、臨床診断、産業用途への導入が遅れる可能性があります。

ロングリードシーケンス市場は、用途、技術、製品、エンドユーザー、地域によって区分されます。用途別では、研究用途と臨床用途に二分されます。技術別では、1分子リアルタイムシーケンス（SMRT）、ナノポアシーケンス、合成ロングリードシーケンスに分類されます。製品別では、機器、消耗品、サービスに区分されます。装置セグメントはさらにシステムとソフトウェアに分類されます。エンドユーザー別では、学術・政府研究機関、製薬・バイオテクノロジー企業、病院・クリニック、その他に分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他の欧州地域）、アジア太平洋（日本、中国、インド、オーストラリア、韓国、その他のアジア太平洋）、アジア太平洋（ブラジル、中国、アフリカ、アラビア、その他の南米地域）で分析されます。

利害関係者にとっての主要メリット

当レポートでは、2022～2032年までのロングリードシーケンス市場分析の市場セグメント、現在の動向、推定・動向、力学を定量的に分析し、ロングリードシーケンス市場の有力な機会を特定します。

市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を記載しています。

ポーターのファイブフォース分析では、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるよう、バイヤーとサプライヤーの潜在力を明らかにします。

ロングリードシーケンス市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。

各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。

市場参入企業のポジショニングはベンチマーキングを容易にし、市場参入企業の現在のポジションを明確に理解することができます。

本レポートには、地域と世界のロングリードシーケンス市場動向、主要企業、市場セグメント、用途セグメント、市場成長戦略の分析が含まれています。

本レポートで可能なカスタマイズ（追加費用とスケジュールが必要です。）

  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡大リスト
  • 過去の市場データ
  • 主要参入企業の詳細（所在地、連絡先、サプライヤー/ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主要調査結果
    • 影響要因
    • 主要投資機会
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
      • 精密医療に対する需要の高まり
      • 提携・共同研究数の増加
      • 主要企業による創薬への取り組みの増加
    • 抑制要因
      • 高い初期投資とコスト
    • 機会
      • 技術進歩の高まり

第4章 ロングリードシーケンス市場：用途別

  • 概要
  • 研究用途
  • 臨床用途

第5章 ロングリードシーケンス市場：技術別

  • 概要
  • 単一分子リアルタイム（SMRT）シーケンス
  • ナノポアシーケンス
  • 合成ロングリードシーケンス

第6章 ロングリードシーケンス市場：製品別

  • 概要
  • 装置
    • ロングリードシーケンス装置市場：タイプ別
  • 消耗品
  • サービス

第7章 ロングリードシーケンス市場：エンドユーザー別

  • 概要
  • 学術・政府研究機関
  • 製薬・バイオテクノロジー企業
  • 病院・クリニック
  • その他

第8章 ロングリードシーケンシング市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • その他
  • ラテンアメリカ・中東・アフリカ
    • ブラジル
    • サウジアラビア
    • 南アフリカ
    • その他

第9章 競争情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2022年

第10章 企業プロファイル

  • Agilent Technologies, Inc.
  • BaseClear B.V.
  • Cantata Bio
  • Element Biosciences
  • FG Technologies
  • GrandOmics
  • Illumina, Inc.
  • MicrobesNG
  • Novogene co., ltd.
  • Oxford Nanopore Technologies plc.
  • PacBio
  • St Vincents Hospital Melbourne
  • TAKARA HOLDINGS INC.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • BGI Genomics
  • CD Genomics
図表

LIST OF TABLES

  • TABLE 01. GLOBAL LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 02. LONG READ SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. LONG READ SEQUENCING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 05. LONG READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME (SMRT) SEQUENCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. LONG READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. LONG READ SEQUENCING MARKET FOR SYNTHETIC LONG READ SEQUENCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. GLOBAL LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 09. LONG READ SEQUENCING MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL INSTRUMENTS LONG READ SEQUENCING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 11. LONG READ SEQUENCING MARKET FOR CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. LONG READ SEQUENCING MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 14. LONG READ SEQUENCING MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. LONG READ SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. LONG READ SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. LONG READ SEQUENCING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. LONG READ SEQUENCING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA LONG READ SEQUENCING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 24. U.S. LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. U.S. LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 26. U.S. LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. U.S. LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 28. CANADA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. CANADA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 30. CANADA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. CANADA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 32. MEXICO LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. MEXICO LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. EUROPE LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE LONG READ SEQUENCING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 41. GERMANY LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. GERMANY LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 43. GERMANY LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. GERMANY LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. FRANCE LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. FRANCE LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 47. FRANCE LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 48. FRANCE LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. UK LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. UK LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 51. UK LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 52. UK LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 53. ITALY LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. ITALY LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 55. ITALY LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. ITALY LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. SPAIN LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. SPAIN LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 59. SPAIN LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. SPAIN LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. REST OF EUROPE LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. REST OF EUROPE LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 63. REST OF EUROPE LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 64. REST OF EUROPE LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 67. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 68. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 69. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 70. JAPAN LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. JAPAN LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 72. JAPAN LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 73. JAPAN LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. CHINA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 75. CHINA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 76. CHINA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 77. CHINA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. INDIA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. INDIA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 80. INDIA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 81. INDIA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 82. AUSTRALIA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. AUSTRALIA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 84. AUSTRALIA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 85. AUSTRALIA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. SOUTH KOREA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 87. SOUTH KOREA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH KOREA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH KOREA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 91. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 92. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 93. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 94. LAMEA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 95. LAMEA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 96. LAMEA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 97. LAMEA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 98. LAMEA LONG READ SEQUENCING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 99. BRAZIL LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 100. BRAZIL LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 101. BRAZIL LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 102. BRAZIL LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 103. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 104. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 105. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 106. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 107. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 108. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 109. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 110. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 111. REST OF LAMEA LONG READ SEQUENCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 112. REST OF LAMEA LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 113. REST OF LAMEA LONG READ SEQUENCING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 114. REST OF LAMEA LONG READ SEQUENCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 115. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 116. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • TABLE 117. AGILENT TECHNOLOGIES, INC.: PRODUCT SEGMENTS
  • TABLE 118. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
  • TABLE 119. BASECLEAR B.V.: KEY EXECUTIVES
  • TABLE 120. BASECLEAR B.V.: COMPANY SNAPSHOT
  • TABLE 121. BASECLEAR B.V.: SERVICE SEGMENTS
  • TABLE 122. BASECLEAR B.V.: PRODUCT PORTFOLIO
  • TABLE 123. CANTATA BIO: KEY EXECUTIVES
  • TABLE 124. CANTATA BIO: COMPANY SNAPSHOT
  • TABLE 125. CANTATA BIO: PRODUCT SEGMENTS
  • TABLE 126. CANTATA BIO: SERVICE SEGMENTS
  • TABLE 127. CANTATA BIO: PRODUCT PORTFOLIO
  • TABLE 128. CANTATA BIO: KEY STRATERGIES
  • TABLE 129. ELEMENT BIOSCIENCES: KEY EXECUTIVES
  • TABLE 130. ELEMENT BIOSCIENCES: COMPANY SNAPSHOT
  • TABLE 131. ELEMENT BIOSCIENCES: PRODUCT SEGMENTS
  • TABLE 132. ELEMENT BIOSCIENCES: PRODUCT PORTFOLIO
  • TABLE 133. ELEMENT BIOSCIENCES: KEY STRATERGIES
  • TABLE 134. FG TECHNOLOGIES: KEY EXECUTIVES
  • TABLE 135. FG TECHNOLOGIES: COMPANY SNAPSHOT
  • TABLE 136. FG TECHNOLOGIES: PRODUCT SEGMENTS
  • TABLE 137. FG TECHNOLOGIES: PRODUCT PORTFOLIO
  • TABLE 138. GRANDOMICS: KEY EXECUTIVES
  • TABLE 139. GRANDOMICS: COMPANY SNAPSHOT
  • TABLE 140. GRANDOMICS: PRODUCT SEGMENTS
  • TABLE 141. GRANDOMICS: PRODUCT PORTFOLIO
  • TABLE 142. GRANDOMICS: KEY STRATERGIES
  • TABLE 143. ILLUMINA, INC.: KEY EXECUTIVES
  • TABLE 144. ILLUMINA, INC.: COMPANY SNAPSHOT
  • TABLE 145. ILLUMINA, INC.: PRODUCT SEGMENTS
  • TABLE 146. ILLUMINA, INC.: PRODUCT PORTFOLIO
  • TABLE 147. ILLUMINA, INC.: KEY STRATERGIES
  • TABLE 148. MICROBESNG: KEY EXECUTIVES
  • TABLE 149. MICROBESNG: COMPANY SNAPSHOT
  • TABLE 150. MICROBESNG: PRODUCT SEGMENTS
  • TABLE 151. MICROBESNG: PRODUCT PORTFOLIO
  • TABLE 152. NOVOGENE CO., LTD.: KEY EXECUTIVES
  • TABLE 153. NOVOGENE CO., LTD.: COMPANY SNAPSHOT
  • TABLE 154. NOVOGENE CO., LTD.: SERVICE SEGMENTS
  • TABLE 155. NOVOGENE CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 156. NOVOGENE CO., LTD.: KEY STRATERGIES
  • TABLE 157. OXFORD NANOPORE TECHNOLOGIES PLC.: KEY EXECUTIVES
  • TABLE 158. OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY SNAPSHOT
  • TABLE 159. OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCT SEGMENTS
  • TABLE 160. OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCT PORTFOLIO
  • TABLE 161. OXFORD NANOPORE TECHNOLOGIES PLC.: KEY STRATERGIES
  • TABLE 162. PACBIO: KEY EXECUTIVES
  • TABLE 163. PACBIO: COMPANY SNAPSHOT
  • TABLE 164. PACBIO: PRODUCT SEGMENTS
  • TABLE 165. PACBIO: PRODUCT PORTFOLIO
  • TABLE 166. PACBIO: KEY STRATERGIES
  • TABLE 167. ST VINCENTS HOSPITAL MELBOURNE: KEY EXECUTIVES
  • TABLE 168. ST VINCENTS HOSPITAL MELBOURNE: COMPANY SNAPSHOT
  • TABLE 169. ST VINCENTS HOSPITAL MELBOURNE: PRODUCT SEGMENTS
  • TABLE 170. ST VINCENTS HOSPITAL MELBOURNE: PRODUCT PORTFOLIO
  • TABLE 171. TAKARA HOLDINGS INC.: KEY EXECUTIVES
  • TABLE 172. TAKARA HOLDINGS INC.: COMPANY SNAPSHOT
  • TABLE 173. TAKARA HOLDINGS INC.: PRODUCT SEGMENTS
  • TABLE 174. TAKARA HOLDINGS INC.: PRODUCT PORTFOLIO
  • TABLE 175. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
  • TABLE 176. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
  • TABLE 177. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
  • TABLE 178. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
  • TABLE 179. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
  • TABLE 180. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 181. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 182. DANAHER CORPORATION: PRODUCT SEGMENTS
  • TABLE 183. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 184. BGI GENOMICS: KEY EXECUTIVES
  • TABLE 185. BGI GENOMICS: COMPANY SNAPSHOT
  • TABLE 186. BGI GENOMICS: SERVICE SEGMENTS
  • TABLE 187. BGI GENOMICS: PRODUCT PORTFOLIO
  • TABLE 188. CD GENOMICS: KEY EXECUTIVES
  • TABLE 189. CD GENOMICS: COMPANY SNAPSHOT
  • TABLE 190. CD GENOMICS: PRODUCT SEGMENTS
  • TABLE 191. CD GENOMICS: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. LONG READ SEQUENCING MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF LONG READ SEQUENCING MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN LONG READ SEQUENCING MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN LONG READ SEQUENCING MARKET (2023-2032)
  • FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 07. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL LONG READ SEQUENCING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. LONG READ SEQUENCING MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. LONG READ SEQUENCING MARKET, BY TECHNIQUE, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME (SMRT) SEQUENCING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR SYNTHETIC LONG READ SEQUENCING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. LONG READ SEQUENCING MARKET, BY PRODUCT, 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR INSTRUMENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR CONSUMABLES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. LONG READ SEQUENCING MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 26. COMPARATIVE SHARE ANALYSIS OF LONG READ SEQUENCING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 27. LONG READ SEQUENCING MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 28. U.S. LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. CANADA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. MEXICO LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. GERMANY LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. FRANCE LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. UK LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. ITALY LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. SPAIN LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. REST OF EUROPE LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. JAPAN LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. CHINA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. INDIA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. AUSTRALIA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. SOUTH KOREA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. BRAZIL LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. SAUDI ARABIA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. SOUTH AFRICA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. REST OF LAMEA LONG READ SEQUENCING MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. TOP WINNING STRATEGIES, BY YEAR (2020-2024)
  • FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2024)
  • FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY (2020-2024)
  • FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 51. COMPETITIVE DASHBOARD
  • FIGURE 52. COMPETITIVE HEATMAP: LONG READ SEQUENCING MARKET
  • FIGURE 53. TOP PLAYER POSITIONING, 2022
  • FIGURE 54. AGILENT TECHNOLOGIES, INC.: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 55. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY SEGMENT, 2023 (%)
  • FIGURE 56. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 57. ILLUMINA, INC.: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 58. ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2023 (%)
  • FIGURE 59. ILLUMINA, INC.: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 60. PACBIO: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 61. PACBIO: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 62. TAKARA HOLDINGS INC.: SALES REVENUE, 2021-2023 ($MILLION)
  • FIGURE 63. TAKARA HOLDINGS INC.: REVENUE SHARE BY SEGMENT, 2023 (%)
  • FIGURE 64. THERMO FISHER SCIENTIFIC INC. : NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 65. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 66. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 67. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 68. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 69. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
目次
Product Code: A14421

The long read sequencing market was valued at $724.43 million in 2022 and is estimated to reach $5,163.41 million by 2032, exhibiting a CAGR of 21.7% from 2023 to 2032. Long read sequencing is a genomic technique that reads longer stretches of DNA compared to traditional methods. It employs innovative technologies like single-molecule sequencing to generate DNA sequences spanning thousands to millions of base pairs. Platforms such as Pacific Biosciences and Oxford Nanopore Technologies utilize techniques such as nanopore sequencing to achieve extended read lengths. Long read sequencing facilitates comprehensive analysis of complex genomic regions, repetitive sequences, and structural variations. Its applications include de novo genome assembly, resolving complex genomic structures, understanding genetic diseases, and exploring microbial diversity. Overall, long read sequencing revolutionizes genomic research by providing detailed and accurate genomic information.

Long Read Sequencing Market - IMG1

The rise in the prevalence of genetic disorders and cancer is indeed a significant driver for the increased demand for long read sequencing technologies. Genetic disorders and cancer are inherently complex diseases influenced by multiple genetic factors, including mutations, structural variations, and genomic rearrangements. Long read sequencing offers the ability to comprehensively analyze the entire genome, enabling researchers and clinicians to identify rare and novel genetic variants associated with these diseases more accurately. For instance, the World Health Organization (WHO) estimated that approximately 400,000 children develop cancer every year worldwide, emphasizing the urgent need for advanced genomic technologies to better understand the genetic basis of cancer and develop targeted therapies. By providing insights into the underlying genetic mechanisms of disease, long read sequencing plays a crucial role in advancing precision medicine initiatives and improving clinical outcomes for patients with genetic disorders and cancer.

In addition, with the decreasing cost of sequencing and increasing awareness of the importance of genomics in various domains, there's a growing demand for comprehensive genomic insights. Long read sequencing provides a deeper understanding of genomic structure and function, allowing researchers to uncover complex genetic variations and better understand the genetic basis of diseases, traits, and evolutionary processes. Thus, the rise in genetic and cancer disorders and the wide application of long read sequencing in the disease diagnosis is potentially diving the market growth.

However, the lack of skilled professionals in the field of long read sequencing is expected to hinder market growth. Operating and interpreting data from long read sequencing platforms require specialized expertise in molecular biology, bioinformatics, and genomics. The shortage of adequately trained personnel may limit the adoption and utilization of long read sequencing technologies, delaying their implementation in research, clinical diagnostics, and industrial applications.

The long read sequencing market is segmented on the basis of application, technique, product, end user, and region. By application, it is bifurcated into research application and clinical application. By technique, the market is categorized into single-molecule real-time sequencing (SMRT), nanopore sequencing and synthetic long read sequencing. On the basis of product, it is segmented into instruments, consumables, and services. The instrument segment is further classified into system and software. By end user, it is segregated into academic and government research institutes, pharmaceutical and biotechnological companies, hospitals and clinics, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global long read sequencing market are Agilent Technologies, Inc. BaseClear BV, Cantata Bio, FG Technologies, Grandomics, MicrobesNG, Novogene co., ltd., Oxford Nanopore Technologies, Pacific Biosciences Inc., CD Genomics, Danaher Corporation, BGI Genomics, St Vincent's Hospital Australia, Takara Holdings Inc., Thermo Fisher Scientific, Inc., Element Biosciences, and Illumina, Inc. Key players operating in the market have adopted product launch, acquisition, partnership and collaboration as their key strategy to expand their product portfolio.

Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the long read sequencing market analysis from 2022 to 2032 to identify the prevailing long read sequencing market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the long read sequencing market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global long read sequencing market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Application

  • Research Applications
  • Clinical Applications

By Technique

  • Nanopore Sequencing
  • Synthetic Long Read Sequencing
  • Single-Molecule Real-Time (SMRT) Sequencing

By Product

  • Instruments
    • Type
    • System
    • Software
  • Consumables
  • Services

By End User

  • Academic and Government Research Institutes
  • Pharmaceutical and Biotech Companies
  • Hospitals and Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Cantata Bio
    • Illumina, Inc.
    • Danaher Corporation
    • Element Biosciences
    • FG Technologies
    • MicrobesNG
    • Oxford Nanopore Technologies plc.
    • CD Genomics
    • BGI Genomics
    • St Vincents Hospital Melbourne
    • Agilent Technologies, Inc.
    • TAKARA HOLDINGS INC.
    • BaseClear B.V.
    • GrandOmics
    • Novogene co., ltd.
    • PacBio
    • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in demand for precision medicine
      • 3.4.1.2. Rise in number of partnership and collaboration
      • 3.4.1.3. The growing initiatives taken by the key players for drug discovery
    • 3.4.2. Restraints
      • 3.4.2.1. High Initial Investment and Cost
    • 3.4.3. Opportunities
      • 3.4.3.1. Rise in technological advancements

CHAPTER 4: LONG READ SEQUENCING MARKET, BY APPLICATION

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Research Applications
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Clinical Applications
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: LONG READ SEQUENCING MARKET, BY TECHNIQUE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Single-Molecule Real-Time (SMRT) Sequencing
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Nanopore Sequencing
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Synthetic Long Read Sequencing
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: LONG READ SEQUENCING MARKET, BY PRODUCT

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Instruments
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
    • 6.2.4. Instruments Long Read Sequencing Market by Type
  • 6.3. Consumables
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Services
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: LONG READ SEQUENCING MARKET, BY END USER

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Academic and Government Research Institutes
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Pharmaceutical and Biotech Companies
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Hospitals and Clinics
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country
  • 7.5. Others
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by region
    • 7.5.3. Market share analysis by country

CHAPTER 8: LONG READ SEQUENCING MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by Application
    • 8.2.3. Market size and forecast, by Technique
    • 8.2.4. Market size and forecast, by Product
    • 8.2.5. Market size and forecast, by End User
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Market size and forecast, by Application
      • 8.2.6.1.2. Market size and forecast, by Technique
      • 8.2.6.1.3. Market size and forecast, by Product
      • 8.2.6.1.4. Market size and forecast, by End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Market size and forecast, by Application
      • 8.2.6.2.2. Market size and forecast, by Technique
      • 8.2.6.2.3. Market size and forecast, by Product
      • 8.2.6.2.4. Market size and forecast, by End User
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Market size and forecast, by Application
      • 8.2.6.3.2. Market size and forecast, by Technique
      • 8.2.6.3.3. Market size and forecast, by Product
      • 8.2.6.3.4. Market size and forecast, by End User
  • 8.3. Europe
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by Application
    • 8.3.3. Market size and forecast, by Technique
    • 8.3.4. Market size and forecast, by Product
    • 8.3.5. Market size and forecast, by End User
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Market size and forecast, by Application
      • 8.3.6.1.2. Market size and forecast, by Technique
      • 8.3.6.1.3. Market size and forecast, by Product
      • 8.3.6.1.4. Market size and forecast, by End User
      • 8.3.6.2. France
      • 8.3.6.2.1. Market size and forecast, by Application
      • 8.3.6.2.2. Market size and forecast, by Technique
      • 8.3.6.2.3. Market size and forecast, by Product
      • 8.3.6.2.4. Market size and forecast, by End User
      • 8.3.6.3. UK
      • 8.3.6.3.1. Market size and forecast, by Application
      • 8.3.6.3.2. Market size and forecast, by Technique
      • 8.3.6.3.3. Market size and forecast, by Product
      • 8.3.6.3.4. Market size and forecast, by End User
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Market size and forecast, by Application
      • 8.3.6.4.2. Market size and forecast, by Technique
      • 8.3.6.4.3. Market size and forecast, by Product
      • 8.3.6.4.4. Market size and forecast, by End User
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Market size and forecast, by Application
      • 8.3.6.5.2. Market size and forecast, by Technique
      • 8.3.6.5.3. Market size and forecast, by Product
      • 8.3.6.5.4. Market size and forecast, by End User
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Market size and forecast, by Application
      • 8.3.6.6.2. Market size and forecast, by Technique
      • 8.3.6.6.3. Market size and forecast, by Product
      • 8.3.6.6.4. Market size and forecast, by End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by Application
    • 8.4.3. Market size and forecast, by Technique
    • 8.4.4. Market size and forecast, by Product
    • 8.4.5. Market size and forecast, by End User
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Market size and forecast, by Application
      • 8.4.6.1.2. Market size and forecast, by Technique
      • 8.4.6.1.3. Market size and forecast, by Product
      • 8.4.6.1.4. Market size and forecast, by End User
      • 8.4.6.2. China
      • 8.4.6.2.1. Market size and forecast, by Application
      • 8.4.6.2.2. Market size and forecast, by Technique
      • 8.4.6.2.3. Market size and forecast, by Product
      • 8.4.6.2.4. Market size and forecast, by End User
      • 8.4.6.3. India
      • 8.4.6.3.1. Market size and forecast, by Application
      • 8.4.6.3.2. Market size and forecast, by Technique
      • 8.4.6.3.3. Market size and forecast, by Product
      • 8.4.6.3.4. Market size and forecast, by End User
      • 8.4.6.4. Australia
      • 8.4.6.4.1. Market size and forecast, by Application
      • 8.4.6.4.2. Market size and forecast, by Technique
      • 8.4.6.4.3. Market size and forecast, by Product
      • 8.4.6.4.4. Market size and forecast, by End User
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Market size and forecast, by Application
      • 8.4.6.5.2. Market size and forecast, by Technique
      • 8.4.6.5.3. Market size and forecast, by Product
      • 8.4.6.5.4. Market size and forecast, by End User
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Market size and forecast, by Application
      • 8.4.6.6.2. Market size and forecast, by Technique
      • 8.4.6.6.3. Market size and forecast, by Product
      • 8.4.6.6.4. Market size and forecast, by End User
  • 8.5. LAMEA
    • 8.5.1. Key market trends, growth factors and opportunities
    • 8.5.2. Market size and forecast, by Application
    • 8.5.3. Market size and forecast, by Technique
    • 8.5.4. Market size and forecast, by Product
    • 8.5.5. Market size and forecast, by End User
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Market size and forecast, by Application
      • 8.5.6.1.2. Market size and forecast, by Technique
      • 8.5.6.1.3. Market size and forecast, by Product
      • 8.5.6.1.4. Market size and forecast, by End User
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Market size and forecast, by Application
      • 8.5.6.2.2. Market size and forecast, by Technique
      • 8.5.6.2.3. Market size and forecast, by Product
      • 8.5.6.2.4. Market size and forecast, by End User
      • 8.5.6.3. South Africa
      • 8.5.6.3.1. Market size and forecast, by Application
      • 8.5.6.3.2. Market size and forecast, by Technique
      • 8.5.6.3.3. Market size and forecast, by Product
      • 8.5.6.3.4. Market size and forecast, by End User
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Market size and forecast, by Application
      • 8.5.6.4.2. Market size and forecast, by Technique
      • 8.5.6.4.3. Market size and forecast, by Product
      • 8.5.6.4.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product mapping of top 10 player
  • 9.4. Competitive dashboard
  • 9.5. Competitive heatmap
  • 9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

  • 10.1. Agilent Technologies, Inc.
    • 10.1.1. Company overview
    • 10.1.2. Key executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Business performance
  • 10.2. BaseClear B.V.
    • 10.2.1. Company overview
    • 10.2.2. Key executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
  • 10.3. Cantata Bio
    • 10.3.1. Company overview
    • 10.3.2. Key executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Key strategic moves and developments
  • 10.4. Element Biosciences
    • 10.4.1. Company overview
    • 10.4.2. Key executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Key strategic moves and developments
  • 10.5. FG Technologies
    • 10.5.1. Company overview
    • 10.5.2. Key executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
  • 10.6. GrandOmics
    • 10.6.1. Company overview
    • 10.6.2. Key executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Key strategic moves and developments
  • 10.7. Illumina, Inc.
    • 10.7.1. Company overview
    • 10.7.2. Key executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
    • 10.7.6. Business performance
    • 10.7.7. Key strategic moves and developments
  • 10.8. MicrobesNG
    • 10.8.1. Company overview
    • 10.8.2. Key executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
  • 10.9. Novogene co., ltd.
    • 10.9.1. Company overview
    • 10.9.2. Key executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
    • 10.9.6. Key strategic moves and developments
  • 10.10. Oxford Nanopore Technologies plc.
    • 10.10.1. Company overview
    • 10.10.2. Key executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio
    • 10.10.6. Key strategic moves and developments
  • 10.11. PacBio
    • 10.11.1. Company overview
    • 10.11.2. Key executives
    • 10.11.3. Company snapshot
    • 10.11.4. Operating business segments
    • 10.11.5. Product portfolio
    • 10.11.6. Business performance
    • 10.11.7. Key strategic moves and developments
  • 10.12. St Vincents Hospital Melbourne
    • 10.12.1. Company overview
    • 10.12.2. Key executives
    • 10.12.3. Company snapshot
    • 10.12.4. Operating business segments
    • 10.12.5. Product portfolio
  • 10.13. TAKARA HOLDINGS INC.
    • 10.13.1. Company overview
    • 10.13.2. Key executives
    • 10.13.3. Company snapshot
    • 10.13.4. Operating business segments
    • 10.13.5. Product portfolio
    • 10.13.6. Business performance
  • 10.14. Thermo Fisher Scientific Inc.
    • 10.14.1. Company overview
    • 10.14.2. Key executives
    • 10.14.3. Company snapshot
    • 10.14.4. Operating business segments
    • 10.14.5. Product portfolio
    • 10.14.6. Business performance
  • 10.15. Danaher Corporation
    • 10.15.1. Company overview
    • 10.15.2. Key executives
    • 10.15.3. Company snapshot
    • 10.15.4. Operating business segments
    • 10.15.5. Product portfolio
    • 10.15.6. Business performance
  • 10.16. BGI Genomics
    • 10.16.1. Company overview
    • 10.16.2. Key executives
    • 10.16.3. Company snapshot
    • 10.16.4. Operating business segments
    • 10.16.5. Product portfolio
  • 10.17. CD Genomics
    • 10.17.1. Company overview
    • 10.17.2. Key executives
    • 10.17.3. Company snapshot
    • 10.17.4. Operating business segments
    • 10.17.5. Product portfolio